Hemostatic Agents Market Size and Trends Worth US$ 5441.5 Mn at 6.4% CAGR by 2025 | Exclusive Report by Fortune Business Insights

The Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights that anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights, titled “Hemostatic Agents Market Size, Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025.” As per the report, in 2017 the global hemostatic agents market was worth US$ 3339.4 Mn. The global market is anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.

The hemostatic agents market in Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility. This is expected to propel the growth rate of the Asia Pacific hemostatic agents market. Meanwhile, the Europe market is likely to expand at a low CAGR due to the presence of a smaller patient pool compared to Asia Pacific and North America.

Request sample copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemostatic-agents-market-100084

The report classifies the global hemostatic agents market in terms of various segments and offers a comprehensive overview. According to the report the hemostatic agents market in North America was valued at US$ 1173 Mn in 2017. The North America market was leading at a global sphere in the same year. According to the report, the trend is unlikely to change during the forecast period 2018-2025. Growth the market witnessed in North America is attributable to the increasing demand for surgical procedure in the region. Besides this, as per a research conducted by the American College of Obstetricians and Gynecologist, in the U.S. the rate of postpartum hemorrhage increased by 25.9% approximately during the last decade. This is likely to fuel the demand for hemostatic agents for surgery and other purposes

Combination Hemostats to Dominate the Global Market

In terms of product type, the combination hemostats segment accounted for 14% of the global market in 2017. Combination hemostats are proven to be very effective and offer faster healing. Combination hemostats are capable of offering efficient hemostasis in shorter time owing to rapid action of thrombin and gelatin. Rising adoption of combination hemostats is anticipated to drive the global hemostatic agents market during the forecast period 2018-2025.

The factors expected to drive the global hemostatic agents market are increasing incidence of hemorrhage during surgery and rising emphasis on blood management. Moreover, innovations in surgical procedure such as robot assisted surgery and rising geriatric population are anticipated to fuel the demand in global hemostatic agents market.

As per data published by the Journal of medical Emergency Services (JEMS), worldwide approximately 5 million people die due to traumatic and non-traumatic hemorrhage. Therefore, the rising cases of traumatic or non-traumatic hemorrhage is likely to enable growth in the global hemostatic agents market.

Baxter Widening its Distribution Network Across Regions

Baxter emerged dominant in the global hemostatic agents market in 2017. The growth witnessed is attributable to its diversification strategy implemented to improve the accessibility of its brands. The trend is unlikely to change and Baxter may continue to dominate the global market during forecast period. Strong brand presence, diversified product portfolio, and intense R&D conducted on hemostatic agents are a few factor contributing to Baster’s expansion. Some of the other companies operating in the global hemostatic agents market are Stryker, CryoLife Inc., Integra Life Sciences, BD, Ethicon LLC., Pfizer Inc., Medtronic, and Biom’up.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemostatic-agents-market-size-and-trends-worth-us-54415-mn-at-64-cagr-by-2025-exclusive-report-by-fortune-business-insights/513423

Source: MarketersMedia

Release ID: 513423

Latest News

S&P 500 notches another record after a muted, mixed day

Jul 17, 2019

NEW YORK — A wobbly day of trading ended with meager gains for U.S. stock indexes on Monday, enough to nudge them further into record territory, as the curtain rose on what's expected to be the weakest earnings reporting season in years. Financial stocks fell even though Citigroup said it made more money last quarter than analysts expected. Energy stocks were also weak, but gains for technology and health care stocks helped tip the S&P 500 and other indexes past the highs set on Friday. The S&P 500 rose 0.53 points, or less than 0.1%, to 3,014.30 after drifting between...

China's economy growth cools further amid US tariff war

Jul 17, 2019

BEIJING — China's economic growth sank to its lowest level in at least 26 years in the quarter ending in June, adding to pressure on Chinese leaders as they fight a tariff war with Washington. The world's second-largest economy grew 6.2% over a year ago, down from the previous quarter's 6.4%, government data showed Monday. Forecasters expected China's economy to rebound in late 2018 but pushed back that target after President Donald Trump raised tariffs on Chinese imports to pressure Beijing over its technology development tactics. Now, economists say the slowdown might extend into next year. Weaker Chinese activity carries...

US stock indexes continue to climb into record territory

Jul 17, 2019

NEW YORK — U.S. stocks were modestly higher in morning trading on Friday, as declines in health care stocks were offset by gains in technology, consumer and industrial company stocks. The gains came a day after the Dow Jones Industrial Average closed above 27,000 points for the first time. Investors remain focused on the Federal Reserve. The Fed is expected to cut its benchmark interest rate later this month for the first time in more than a decade to help counter slowing growth. The Dow rose 120 points, or 0.5%, to 27,210 as of 11 a.m. ET. The Standard &...

Pelosi ready for deal on borrowing limit, spending levels

Jul 17, 2019

WASHINGTON — House Speaker Nancy Pelosi says she wants to complete a deal with President Donald Trump this month that would raise the government's borrowing limit and set spending levels for the coming budget year. Pelosi's office says the California Democrat spoke twice with Treasury Secretary Steven Mnuchin on Thursday, and she told reporters she is convinced the double-barreled negotiation needs to be completed before Congress leaves Washington for its August recess. Mnuchin has been urging lawmakers to raise the so-called debt limit soon, warning that the government risks defaulting on U.S. obligations in early to mid-September. Pelosi and Capitol...

The Latest: Markets end up after Powell hints at rate cut

Jul 17, 2019

WASHINGTON — The Latest on Federal Reserve Chairman Jerome Powell's presentation of the Fed's semi-annual monetary report to Congress. (all times local) 7:20 p.m. Testimony by Chairman Jerome Powell to a House Committee about the economic outlook led investors to send stock prices up, bond yields down and the value of the U.S. dollar lower on expectations of lower interest rates. The S&P 500 index briefly traded over 3,000 for the first time. Expectations of a pending rate cut drew additional support Wednesday when the Fed released the minutes of its June 18-19 meeting. Some businesses, particularly in manufacturing, have...

Broaden News
Search

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Contact us: sales@managethenumbers.com

Subscribe to our newsletter!

Name

Email